HIV/AIDS
RSSArticles
-
Dalbavancin — Formulary Considerations
Dalbavancin is a lipoglycopeptide antibiotic for intravenous administration with activity against Gram-positive organisms, including methicillin resistant Staphylococcus aureus that is distinguished by its extraordinarily long serum half-life that allows once weekly dosing. -
ID Grand Rounds — Stanford: Female, 52, with Fever and Progressive Weakness
A 52-year-old woman with no significant past medical history presented to Stanford Hospital in July, 2014, with fever and progressive weakness. She had been in her usual state of health until the day prior to admission, when she began to feel fatigued with subjective fevers and “restless legs.” -
Treating Latent Tuberculosis Infection
Latent tuberculosis infection (LTBI) is a common reason for referral to infectious disease specialists. For the past few decades the standard therapy in the United States has been isoniazid for 9 months. -
Fungus from the Pharmacy: An Unusual Outbreak of Nosocomial Fungemia
-
Rickettsialpox in North Carolina
-
Outbreak of Mycobacterium Tuberculosis in African Mongooses and Meerkats: What, Me Worry?
-
VRSA Has Arrived
-
Are your staff washing their hands of basic practices?
-
APIC, CDC defend efforts in light of Tribune report
-
Lax infection control cited in tissue recall